Abstract
Introduction
Improvement of patient safety, including medication safety, has been viewed as one of the most important objectives in global health policy [1, 2] . It is widely recognized that the majority of adverse events in healthcare are related to medicines [3, 4] . A prescription is an essential means of communication between physicians, pharmacists and patients. However, it is also one potential source of errors that could endanger medication safety [3, [5] [6] [7] [8] [9] . Conventional prescriptions (paper, telephone, fax) have several well-known problems such as legibility or interpretation problems due to physicians' poor handwriting, leading to dispensing errors at pharmacies [8] . There is also the risk of prescription forgeries. In addition, the management of patients' overall medication has been difficult because the necessary information has been scattered rather than collected in one particular place [10, 11] . During the past few decades an electronic prescription (ePrescription) system has been promoted and adopted as one potential tool for improving medication safety by eliminating the problems related to conventional prescriptions [12, 13] .
In the European Union, ePrescribing is interpreted as "the process of electronic transfer of a prescription by a healthcare provider to a pharmacy for retrieval of the medicine by the patient" [14] .
Dispensing information is also recorded electronically. However, the term ePrescription may have different meanings and the systems may vary between countries [12, 15, 16] . For example, in some countries ePrescribing comprises only electronic issuing and data transmission. A fully operational and nationwide ePrescription system has been implemented in only a few European countries, among them Denmark, Sweden, Estonia, Iceland, and Finland [12, 14] . ePrescriptions are also widely used in the United States [15] and Canada [17] , and pilots employing them have been planned or carried out in many countries across Europe [12, 14] .
Studies concerning the impacts of electronic prescribing systems on medication safety have been conducted in various settings, primarily in hospitals [18] [19] [20] . From the pharmacy perspective, previous studies have shown that ePrescribing improves the quality and safety of prescriptions and hence improves patient safety [21] [22] [23] . It has been proposed that improvements in quality and safety result from fewer prescription errors [23] [24] [25] , less misinterpretation of, or ambiguity in, prescriptions [21, [23] [24] [25] [26] [27] , and fewer prescription forgeries [26] . In addition, an ePrescription can support the management of the patient's medication treatment because it allows pharmacies to view all the patient's prescription information [24, 26] . Despite the several positive effects of ePrescriptions, many studies have also reported that they are a potential source of medication errors [21, 23, [26] [27] [28] [29] [30] [31] .
These studies have highlighted the possibility that ePrescriptions might increase the risk of incorrect or ambiguous prescribing: for example, incorrect medication, incorrect dosage instructions, or incorrect medicine quantity.
The aim of this study was to explore pharmacists' opinions regarding the impacts of ePrescriptions on medication safety in Finnish community pharmacies. Further objectives were to explore how often pharmacists have perceived ambiguities or errors in ePrescriptions, and what kinds of ambiguities or errors have appeared.
Materials and Methods

Study context
In Finland (excluding the Åland Islands, which constitute an autonomous and monolingual Swedish region of Finland), a fully operational and nationwide ePrescription system has been mandated by law to be implemented in steps in all community pharmacies in 2012, in public healthcare in 2013, and in private healthcare in 2015 [32] . All healthcare providers will be obliged to implement the system by 2017, and thereafter conventional prescriptions will be allowed only in special cases, such as technical system failures. Finnish community pharmacies dispensed nearly 39 million ePrescriptions in 2014, which was approximately 75% of all prescriptions dispensed [33, 34] . In 2015, pharmacies dispensed over 49 million ePrescriptions, which is over 90% of all prescriptions dispensed [34] .
In Finland, an ePrescription is signed and transferred electronically by a physician and entered into a centralized database called the Prescription Centre [32] . The Prescription Centre contains all electronic prescriptions and the dispensing records entered on them by pharmacies. ePrescriptions can be dispensed in any Finnish pharmacy. At the pharmacy, ePrescriptions are processed in the pharmacy system, which searches for ePrescriptions in the Prescription Centre. At the pharmacy and in the physician's practice, the patient's consent must always be obtained to access the patient's information held in the Prescription Centre. Only pharmacy staff with a pharmaceutical education are permitted to use the Prescription Centre. These are pharmacists (M.Sc. in pharmacy) and dispensers (B.Sc. in pharmacy). A pharmacist has a five-year and a dispenser a three-year university education. The aims of ePrescriptions were to make the prescribing and dispensing processes easier and more efficient and to improve medication safety in Finnish healthcare [32, 35] . Improvements in medication safety were expected to be achieved through the enhanced management of patients' overall medication because prescriptions are visible in the Prescription Centre, thus making it easier to detect drug-related problems (e.g. drug interactions, duplicative therapy, or adverse drug reactions), and also by reducing dispensing errors thanks to less ambiguity of ePrescriptions in community pharmacies [35] . ePrescribing has also been expected to reduce prescription forgeries.
Data collection
A cross-sectional postal survey was conducted in the autumn of 2014. The questionnaire was sent to a random sample (to one-third) of dispensers (n = 1004) and pharmacists (n = 228) working in community pharmacies. The sample was collated from the registers of The Finnish Pharmacists' Association and The Finnish Pharmacists' Society. The Åland Islands were excluded from the study because ePrescriptions have not been implemented there. A total of 1232 questionnaires were mailed.
One reminder was sent to each recipient. The response period was two weeks in both mailing rounds.
The questionnaire was available in Finnish and Swedish, both of which are official languages in Finland.
The four-page questionnaire contained 23 questions, both structured and open-ended and also Likert scale questions. The main themes of the questions concerned the usability of the ePrescription system, the impacts of ePrescriptions on the dispensing process and medication safety, and the main benefits and problems of ePrescriptions. The questions were designed on the basis of the objectives of ePrescriptions as set by law [32] , the anticipated impacts of ePrescriptions [35] , and some previous studies [26, 36] . The questionnaire was piloted with some pharmacist colleagues with experience in processing ePrescriptions and in two local pharmacies in the spring of 2014. Minor modifications were made to the questionnaire on the basis of the pilot. This paper examines the responses to questions concerning the impacts of ePrescriptions on medication safety and perceived ambiguities or errors in ePrescriptions.
The respondents' opinions on medication safety were measured with eight statements covering medication safety issues. The statements were designed on the basis of the Government proposal concerning the anticipated impacts on medication safety of ePrescriptions before they were introduced (see Study context) [35] . The respondents were instructed to answer using a five-point Respondents who reported they did not work in a pharmacy at that particular time were asked to return the questionnaire uncompleted. A translated version of the questionnaire is available as supplementary material.
Data analysis
In the analyses, pharmacists and dispensers were combined (except for the results concerning background characteristics) because of their similar job descriptions regarding medicine dispensing (see Study context). There were no statistically significant differences between respondents with these two academic degrees in the study questions discussed in this paper. Thus, in the results, the term 'pharmacists' refers to both pharmacists and dispensers. In addition, some of the answers in Likert scale were combined: I fully agree and I agree somewhat, and I disagree somewhat and I fully disagree. The data were analyzed with SPSS Statistics for Windows, Version 21.0 (SPSS Inc., Chicago, IL, USA) using frequencies, percentages, and cross-tabulation for descriptive analysis.
Differences between groups were tested using the χ 2 test and Fisher's test. The level of statistical significance was defined as p-values < 0.05.
Ethical statement
The study setting and research process were in accordance with the local and national ethical instructions for research (Finnish  Advisory  Board  on  Research  Integrity: http://www.tenk.fi/en/ethical-review-human-sciences). According to the instructions, this study did not require ethical approval.
Results
Out of the 1232 questionnaires mailed, a total of 800 were returned after one reminder. However, 22
(15 dispensers and 7 pharmacists) of the questionnaires returned were excluded from the study because the respondents reported that they currently did not work in a community pharmacy, and hence 778 questionnaires were included in the study. Thus, the final study sample was 1210 (989 dispensers and 221 pharmacists). A total of 635 (64%) dispensers and 143 (65%) pharmacists returned the completed questionnaire.
The representativeness of the study population compared with the target population was analyzed with respect to age and gender (Table 1 ). This showed the study population to be representative of the target population in terms of age and gender with the exception of dispensers aged 30-39, who
were under-represented (p = 0.001). Almost all of the respondents processed ePrescriptions daily (Table 1) . Most of the respondents reported that ePrescriptions represented over 75% of all prescriptions processed daily.
( Table 1) 
Respondents' opinions on the impact of ePrescriptions on medication safety
The majority of the respondents felt that ePrescriptions improve medication safety in many areas:
they lower the number of prescription forgeries, reduce the risk of dispensing errors, promote better management of the patient's overall medication, facilitate monitoring of drug interactions and duplicative therapy, and lower the risk of incorrect interpretation of a prescription (Figure 1 ).
However, the respondents' opinions were divided as regards the statements "ePrescriptions contain fewer ambiguities than paper prescriptions", and "ePrescription does not promote monitoring of adverse drug reactions".
( Figure 1) 
Respondents' perceived ambiguities and errors in ePrescriptions
Many respondents (32%) reported that they had weekly perceived ambiguities or errors in ePrescriptions that had required clarification during the dispensing process ( Figure 2 ). Almost onefifth (18.6%) of the respondents had perceived such ambiguities or errors daily or almost daily. Some statistically significant differences were found in perceived ambiguities or errors between age, the proportion of ePrescriptions out of the prescriptions processed daily, and the number of prescriptions dispensed per year at the pharmacy (Table 2 ).
( Figure 2) ( Table 2) The three most common ambiguities or errors that pharmacists perceived in ePrescriptions were incorrect total amount of medication, missing notification of exceptional dosage instructions or exceptional purpose of use (SIC!), and unclear or incorrect dosage instructions (Table 3) . Incorrect strength and incorrect pharmaceutical form were also quite commonly experienced problems in ePrescriptions.
( Table 3) 
Discussion
According to this study, pharmacists considered that ePrescriptions improve medication safety in Finnish community pharmacies in many areas. Most pharmacists thought that ePrescriptions reduce prescription forgeries, misinterpretation of prescriptions and dispensing errors, and facilitate the management of patients' overall medication. These were also the main impacts of ePrescriptions on medication safety anticipated before they were introduced in Finland [35] . Many previous studies have reported similar findings concerning improved medication safety in community pharmacies [21, [23] [24] [25] [26] .
However, the findings of this study indicate that ePrescriptions have not succeeded in eliminating all types of ambiguities and errors in prescriptions in Finland. Quite a number of pharmacists in our study reported errors or ambiguities such as misplaced, missing or unclear prescription information.
In addition, inaccuracies in our study were also attributed to physicians. Our study findings are in line with previous studies [21, 26, 30, 31] .
The ambiguities and errors found in this study can be divided into two types. First, inexact prescription information (e.g. misplaced or missing information) and second, incorrect prescription information (e.g. unclear/incorrect dosage instructions or incorrect strength or pharmaceutical form).
Misplaced or missing prescription information can delay the dispensing process at the pharmacy and might cause patient dissatisfaction toward customer service. In the worst case, delays can prevent patients from starting their medication on time. In addition, unclear or incorrect prescription information can cause serious harm to patients and jeopardize favorable medication therapy outcomes.
A novel technology seems to generate new kinds of problems in prescribing. Inexactly or incorrectly entered prescription information probably results from the physician's failure to complete the prescription correctly: for example, entering prescription information in the wrong data fields or incorrectly selecting information from the system. Previous reports have shown that one reason for lack of clarity in dosage instructions is that physicians use abbreviations that may lead to the misinterpretation of instructions in pharmacies [26, 37, 38] . Moreover, some errors or ambiguities required clarifications from a physician, which delayed dispensing.
It has been proposed that poor design of prescribing systems (e.g. poorly designed drop-down menus or data fields) is one factor that can cause the physician to select prescription information incorrectly, resulting in the risk of prescription errors [30, 31, [39] [40] [41] [42] . In addition, one previous study has found that physicians' heavy workloads, carelessness and the lack of professional skills contribute to the occurrence of medication errors [43] . On the other hand, the easy use and consistency of prescribing systems have been reported to help reduce medication errors [44, 45] . Nevertheless, electronic prescribing systems should be developed that enable physicians to write more complete, accurate, and unambiguous ePrescriptions. For example, the system should direct the user to make prescription entries in the correct fields and, where necessary, physicians should be trained in the use of the ePrescription system. This study had some strengths and some limitations. One strength is that the findings are based on a fully operational ePrescription system that is in nationwide use. In addition, the respondents' experiences were based on their daily use of ePrescriptions. The study sample was randomly selected from registers that cover most Finnish dispensers and pharmacists. Moreover, the response rates (64% and 65%) were similar to or higher than for some earlier surveys sent to pharmaceutical staff [26, 46, 47] . The respondents also represented the target population quite well, with the exception of dispensers aged 30-39. The response rate for each question was also high (97-99%) and there was only very little missing information, making the results more reliable. We therefore suggest that our study results can be generalized to apply to all Finnish community pharmacists. However, it should be noted that the results of this study are based on self-reports from community pharmacists. Thus, there is the possibility of over-or underestimation in study questions related to perceived ambiguities and errors in ePrescriptions. In the future therefore, the actual incidence of ePrescription errors in community pharmacies should be investigated using different methods, for example observational research. In addition, this study was conducted in Finland and there are differences in ePrescription systems, its definitions, and stages of implementation between countries [12, 15, 16] .
The present study adds new information in this study field [25, 26, 31, 48] . First, our study was quantitative and included large amounts of data, while previous studies have been qualitative and thus used only small amounts of data [23, 24, 31] . Second, the present study focused more precisely on medication safety and how it has been affected by the introduction of ePrescriptions. In some previous studies, 'safety' has only been one part of the study and has not been studied in depth, or the term 'safety' has been defined imprecisely [23, 25, 26] . Moreover, our study findings shed more light on the different aspects of medication safety, something that the law also seeks to achieve in Finland [32] .
Conclusions
According to Finnish community pharmacists, the introduction of ePrescriptions has promoted medication safety in many areas, as anticipated. However, ambiguities or errors are common in ePrescriptions. Furthermore, some of these ambiguities or errors can delay dispensing, whereas others can cause serious risks to the patient. The ePrescription system needs further development so that it better supports correct prescribing and hence smooth and safe dispensing.
Summary table
What is already known on the topic -A fully operational and nationwide electronic prescription (ePrescription) system has been implemented in only a few European countries, one being Finland. -The use of ePrescriptions have the potential to improve the quality of patient care at the pharmacy. -Only a limited number of studies focus on the impacts of ePrescriptions on medication safety from the pharmacists' point of view.
What this study has added to our knowledge -ePrescriptions have improved medication safety in many areas, particularly by reducing prescription forgeries, the misinterpretation of prescriptions, and the risk of dispensing errors, and facilitated better management of the patient's overall medication. -Ambiguities and errors are still common in ePrescriptions.
-Ambiguities and errors can be divided into two types; those which can delay dispensing at the pharmacy, and those which pose a risk to medication safety. Some of the respondents did not report their gender or age, how often they processed ePrescriptions, the proportion (%) of prescriptions processed daily that are ePrescriptions, pharmacy location, or the number of prescriptions per year at the pharmacy. Highlights -In Finland, ePrescriptions have improved medication safety, particularly by reducing prescription forgeries, the misinterpretation of prescriptions, and the risk of dispensing errors, and facilitated better management of the patient's overall medication. -Ambiguities and errors are still common in ePrescriptions. -Some of ambiguities or errors can delay dispensing, whereas others can cause serious risks to the patient. -The ePrescription system needs further development so that it better supports correct prescribing and hence smooth and safe dispensing.
